Why You Keep Hearing About Risk Scores Before Heart Surgery
If you or a family member has been told that heart surgery is necessary, someone on the medical team has almost certainly run a risk calculation. You may have heard phrases like "your risk score is low" or "your EuroSCORE puts you in a higher category." These numbers matter — they inform surgical planning, guide treatment decisions, and in some cases determine whether you are offered surgery at all versus a catheter-based alternative.
As a fellowship-trained cardiovascular and thoracic surgeon, I use risk models every day. They are genuinely useful tools, but they are not crystal balls. Understanding what these calculators actually measure — and what they miss — is one of the most important things you can do as a patient facing a cardiac surgery decision.
The two dominant risk models in cardiac surgery worldwide are the STS Predicted Risk of Mortality (developed and maintained by the Society of Thoracic Surgeons in North America) and the EuroSCORE II, the European cardiac surgery risk score used extensively across Europe, Asia, the Middle East, and many other regions. This article focuses on EuroSCORE II — what it is, how it works, how it compares to the STS model, and what you should ask your surgeon about it.
What Is the EuroSCORE II Calculator and How Does It Work?
EuroSCORE stands for the European System for Cardiac Operative Risk Evaluation. The original EuroSCORE was introduced in 1999 based on data from nearly 20,000 patients undergoing heart surgery across 128 centers in eight European countries. It was a logistic regression model — essentially a mathematical equation that weighs various patient factors and produces an estimated probability of dying during or shortly after surgery (in-hospital or 30-day mortality).
The original model served the field well for over a decade, but as surgical techniques improved and mortality rates dropped, the original EuroSCORE began to overestimate risk — sometimes significantly. A patient predicted to have a 10% chance of dying might have actually faced a risk closer to 3-4% with modern techniques. This mattered enormously because inflated risk scores could steer patients away from conventional surgery and toward less-proven alternatives.
In 2012, EuroSCORE II was released. It was built on a new dataset of over 22,000 patients from 154 hospitals across 43 countries. The updated EuroSCORE II calculator incorporated better statistical methods and recalibrated the model to reflect contemporary outcomes. It is the version in use today.
What Patient Factors Does EuroSCORE II Measure?
The EuroSCORE II calculator collects 18 variables grouped into three categories:
- Patient-related factors: age, sex, kidney function (creatinine clearance), the presence of conditions outside the heart that limit mobility or daily function (extracardiac arteriopathy, poor mobility, previous cardiac surgery, chronic lung disease, active endocarditis, diabetes on insulin)
- Heart-related factors: NYHA class (how much heart failure symptoms limit activity), angina class, left ventricular function, recent heart attack, pulmonary hypertension
- Surgery-related factors: urgency of the operation (elective, urgent, emergent, or salvage), the weight of the intervention (isolated CABG vs. combined procedures), and whether the thoracic aorta is being operated on
Each factor is assigned a coefficient in the logistic equation, and the final output is a single number: your predicted risk of operative mortality expressed as a percentage.
EuroSCORE vs STS: How the Two Major Risk Models Compare
Patients in the United States will more commonly encounter the STS risk score, while patients evaluated in Europe, India, South America, and many other regions will see EuroSCORE II. But with the global nature of modern medicine, it is not unusual to see both referenced — especially when decisions about TAVR versus surgical aortic valve replacement are being discussed.
Here is how they differ:
- Data source: The STS model is built on the STS Adult Cardiac Surgery Database, which captures data from approximately 95% of cardiac surgery programs in the United States. EuroSCORE II is based on a multinational European dataset. Both are large, but they reflect different patient populations, healthcare systems, and practice patterns.
- Procedure-specific vs. general: The STS model has separate, procedure-specific calculators — one for isolated CABG, one for isolated valve surgery, one for combined CABG plus valve, and so on. This allows more granular predictions. The EuroSCORE II calculator, by contrast, uses a single model for all adult cardiac surgery and adjusts for procedure type as one of its variables.
- Calibration: Because the STS database is continuously updated (new data flows in annually), the STS models are periodically recalibrated to keep pace with improving outcomes. EuroSCORE II, while a major improvement over the original, was calibrated against data collected primarily in 2010 and has not been formally recalibrated with the same frequency. Studies published in the European Journal of Cardio-Thoracic Surgery and other journals have shown that EuroSCORE II can still overestimate risk in certain subgroups, particularly for lower-risk patients, while it may underestimate risk in the highest-risk patients.
- Outcomes measured: EuroSCORE II predicts in-hospital mortality only. The STS models predict operative mortality (in-hospital or within 30 days) but also predict major morbidity — stroke, renal failure, prolonged ventilation, deep sternal wound infection, and reoperation. This broader outcome picture is clinically very valuable.
When people refer to the debate around EuroSCORE vs STS, they are usually discussing which model performs better at discrimination (correctly ranking who is high vs. low risk) and calibration (correctly predicting the actual percentage). In general, most comparative studies suggest that the STS score has better calibration for North American populations, while EuroSCORE II performs reasonably well in European cohorts but can lose accuracy when applied outside its original dataset or in specific subpopulations.
If you have been quoted a risk score and are not sure which model was used — ask. It matters. And if you want to explore what your numbers look like across models, our free cardiac surgery risk calculator can be a helpful starting point.
Where EuroSCORE II Falls Short — And Why That Matters to You
No risk model is perfect, and as a surgeon who reviews cases from around the world through our second opinion process at WhiteGloveMD, I see the consequences of over-reliance on risk scores regularly. Here are the most important limitations of EuroSCORE II that patients and families should understand:
1. It Does Not Capture Frailty Well
Frailty — the overall biological vulnerability that comes with aging, deconditioning, malnutrition, or chronic illness — is arguably the single most important predictor of poor outcomes after cardiac surgery in older adults. EuroSCORE II includes "poor mobility" as a surrogate for frailty, but this is a crude, binary variable (either you have severely impaired mobility or you do not). It does not capture sarcopenia, cognitive decline, nutritional status, or the many other dimensions of frailty that experienced surgeons assess when they meet a patient.
2. It Predicts Mortality, Not Quality of Life
The EuroSCORE II output tells you the probability of dying from the surgery. It says nothing about your chances of having a stroke, requiring prolonged rehabilitation, or being unable to return to independent living. For many patients and families, these outcomes matter as much as — or more than — survival alone.
3. It Does Not Account for Surgeon or Hospital Volume
Where your surgery is performed and who performs it has a measurable impact on outcomes. High-volume centers with experienced surgical teams consistently deliver lower mortality and complication rates. EuroSCORE II does not factor this in. A patient with a EuroSCORE II of 4% might face very different actual risk depending on whether the operation takes place at a high-volume academic center or a low-volume community hospital.
4. It Can Be Used to Justify Decisions It Was Not Designed to Make
This is perhaps the most important point. EuroSCORE II and similar calculators were designed to estimate risk — not to make treatment decisions. Yet in practice, these scores are frequently used as thresholds: "Your EuroSCORE is above X, so you should have TAVR instead of surgery," or "Your score is too high for surgery." Guidelines from the ACC/AHA and the European Society of Cardiology do reference risk scores when categorizing patients, but the actual decision should integrate far more information than a single number. Clinical judgment, anatomic considerations, patient preferences, life expectancy, and the expertise of the surgical team all play critical roles.
I have reviewed many cases where a patient was told surgery was "too risky" based on a risk score, only to find on detailed review that the score was being misapplied, key variables were entered incorrectly, or important clinical context was being ignored. This is one of the most compelling reasons to seek a cardiac surgery second opinion before making a final decision.
How to Use Your European Cardiac Surgery Risk Score Wisely
If you have been given a EuroSCORE II result, here is practical advice on what to do with it:
- Ask which model was used. Confirm whether the number you were quoted is from EuroSCORE II, the original EuroSCORE (which should no longer be used but occasionally still is), or the STS score. Each means something different.
- Ask what specific outcome it predicts. EuroSCORE II predicts mortality. If you want to understand your risk of stroke, kidney injury, or prolonged ICU stay, you need additional information.
- Understand that you are not a statistic. A EuroSCORE II of 3% means that in a group of 100 patients with similar characteristics, roughly 3 would be expected to die. It does not tell you whether you will be one of those 3 or one of the 97. Individual factors not captured by the model — your functional status, your anatomy, your surgeon's experience — shift the odds in ways the calculator cannot quantify.
- Do not let a number replace a conversation. The most important risk assessment in cardiac surgery happens when an experienced surgeon reviews your imaging, examines you, understands your goals, and gives you an honest, individualized assessment. A risk score is a starting point for that conversation, not a substitute for it.
- Get a second set of eyes. If a risk score is being used to steer your treatment in a particular direction — especially away from an option you were hoping for — it is reasonable and appropriate to seek another opinion. An independent surgeon reviewing your full clinical picture can confirm or challenge that assessment.
When a Second Look at Your Risk Score Changes Everything
I have seen cases where patients were told their operative risk was 8-10% based on EuroSCORE II, only to find on careful review that variables were entered incorrectly — a creatinine value from an acute illness instead of a baseline value, an NYHA class overestimated because of deconditioning rather than true heart failure, or a "previous cardiac surgery" box checked for a prior catheterization that was not actually a surgical procedure. Small input errors create meaningful output errors. In some of these cases, the corrected risk estimate was half of the original, fundamentally changing the treatment recommendation.
This is not a criticism of the physicians involved — risk calculators are filled out quickly in busy clinical environments, and mistakes happen. But the downstream consequences of an inaccurate risk score can include being denied a surgery that could add years to your life or being pushed toward a procedure that may not serve you as well in the long term.
Risk scores are tools. They are most valuable when used by experienced clinicians who understand their strengths and their blind spots. They should inform your decision, but they should never be the only voice in the room.
If you have been given a EuroSCORE II or STS risk estimate and are unsure whether the recommended treatment plan is right for you, a WhiteGloveMD second opinion can help. Our team, led by a fellowship-trained cardiovascular and thoracic surgeon, will review your complete medical records, imaging, and risk calculations to give you an independent, expert assessment — so you can move forward with confidence. Start your review today.